Search clinical trials for: Real time High-Dose-Rate prostate brachytherapy in combination with stereotactic prostate radiothera

Total 12 results

David Büchser

Recruiting

HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer (BRAchySABR)

Prostatic Neoplasm

Spain
Centre Georges Francois Leclerc

Recruiting

Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in Patients With Prostate Adenocarcinoma Adverse Intermediate Risk or High Localized Risk (SHORT)

To Evaluate the Rate of Digestive and Urinary Toxicity

France
British Columbia Cancer Agency

Active, not recruiting

Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer

Prostate Cancer

Canada
British Columbia Cancer Agency
BC Cancer Foundation

Recruiting

LDR vs. HDR Brachytherapy for Prostate Cancer (LDR/HDRmono)

Prostate Cancer

Canada
British Columbia Cancer Agency
University of British Columbia; Vancouver Prostate Centre; BC Cancer Foundation

Recruiting

Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer (BrachyTRACKS)

Localized Prostate Carcinoma

Canada
CHU de Quebec-Universite Laval

Recruiting

A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.

Prostate Cancer

Canada
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Recruiting

Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer

Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8

United States
N.N. Petrov National Medical Research Center of...

Recruiting

HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer

Biochemical Relapse Free Survival | Complications Rates (Erectile Dysfunction, GI, GU Complications)

Russian Federation
British Columbia Cancer Agency

Recruiting

5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) (PROMPT)

Oligometastatic Prostate Cancer

Canada
CHU de Quebec-Universite Laval
Sunnybrook Health Sciences Centre; Université de Montréal

Completed

HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate Cancer (HDRvsLDR)

Prostate Cancer

Canada
University Hospital, Grenoble
Clinical Investigation Centre for Innovative Technology Network; Koelis

Recruiting

Prostate Interstitial Brachytherapy With I125 Implant With Target Dose Supplementation in the Tumor Volume Guided by TRINITY® PERINE 3D System (FOCUS-BOOST)

Prostate Cancer

France
Julio Ramirez
University of Louisville

Terminated

Patients Response to Early Switch To Oral:Osteomyelitis Study (PRESTO:Osteo)

Osteomyelitis

United States

Search clinical trials for: Real time High-Dose-Rate prostate brachytherapy in combination with stereotactic prostate radiothera

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations